共 400 条
[1]
De Ferranti SD(2019)Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement from the American Heart Association Circulation 139 e603-e634
[2]
Steinberger J(2015)Familial hypercholesterolaemia in children and adolescents: Gaining decades of life by optimizing detection and treatment Eur Hear J 36 2425-2437
[3]
Urbina EM(2021)Prevention starts from the crib: The pediatric point of view on detection of families at high cardiovascular risk Ital J Pediatr 47 1-6
[4]
Zachariah JP(2022)Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: a new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group Atherosclerosis. 349 233-239
[5]
Zaidi AN(2013)Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease Eur Heart J 34 3478-3490
[6]
Ameduri R(2022)2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk Front Genet. 13 912510-188
[7]
Baker A(2020)Nutraceuticals in Paediatric Patients with Dyslipidaemia Eur Heart J. 41 111-28
[8]
Gooding H(2022)Raccomandazioni per la prevenzione in età pediatrica dell’aterosclerosi Nutrients 14 569-264
[9]
Kelly AS(2000)Long-Term Safety and Efficacy of a Cholesterol-Lowering Diet in Children with Elevated Low-Density Lipoprotein Cholesterol: Seven-Year Results of the Dietary Intervention Study in Children (DISC) Riv Ital Pediat 26 13-59
[10]
Mietus-Snyder M(2001)Safety of a fat-reduced diet: The Dietary Intervention Study in Children (DISC) Pediatrics 107 256-333